The Core of Wall Street Is Rotten
I remember feeling repulsed when I first read that Martin Shkreli, CEO of Turing Pharmaceuticals, raised the price of its proprietary drug, Daraprim, by 5,000 percent. This increase caused the price of each pill to go from $13.50 to $750.
At the time, I did some research on the disease that Daraprim is prescribed to treat. It’s called toxoplasmosis. According to the Mayo Clinic, this disease can cause “extremely serious complications” for infants born to infected mothers and for people with weakened immune systems.
Read the rest of the article at The Huffington Post.